+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro synergistic activity of piperacillin-tazobactam combination against beta-lactam antibiotics resistant strains of Enterobacteriaceae



In vitro synergistic activity of piperacillin-tazobactam combination against beta-lactam antibiotics resistant strains of Enterobacteriaceae



Pathologie-Biologie 39(5): 374-378



The combination of piperacillin and tazobactam was studied in a microtiter checkerboard assay against 160 strains of Enterobacteriaceae selected for their resistance pattern to amoxicillin, ticarcillin, cephalothin and cefotaxime. Mean FIC indices were respectively 0.02, 0.17 and 0.01 for RRSS strains of E. coli, K. pneumoniae and P. mirabilis. Mean FIC indices were 0.03 for RRRI/R strains of K. pneumoniae producing a broad spectrum beta-lactamase, but the synergistic effect was out of therapeutic range for 16 strains of 20. Mean FIC indices were 0.53, 0.90, 0.55, 0.10 and 0.21 respectively against RSRS strains of E. coli, E. cloacae, S. marcescens, M. morganii and P. vulgaris. Mean FIC indices were 0.02, 0.07, 0.02 and 0.01 against RRRS/R strains of E. coli, E. cloacae, S. marcescens and M. morganii but they were in a therapeutical range (piperacillin less than or equal to 8 mg/l and tazobactam less than or equal to 4 mg/l) respectively for 7, 0, 4 and 10 strains of 10 in each species. Tazobactam restored the antibacterial activity of piperacillin against enterobacterial strains mainly producing a penicillinase or a cephalosporinase for M. morganii and P. vulgaris.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040393796

Download citation: RISBibTeXText

PMID: 1652728


Related references

In vitro synergistic activity of piperacillin combined with tazobactam against beta lactam resistant strains of enterobacteriaceae. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 31: 117, 1991

A three-dimensional model to study a combination of three antibiotics in vitro. Application to the bactericidal activity of piperacillin, tazobactam and amikacin against five strains of enterobacteria according to their beta-lactam resistance patterns. Pathologie Biologie 46(1): 67-72, 1998

Antibacterial in vitro activity of piperacillin-tazobactam in combination with netilmicin or amikacin against amoxicillin-resistant strains of Enterobacteriaceae. Pathologie Biologie 43(3): 208-214, 1995

In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Klebsiella pneumoniae Strains. Antimicrobial Agents and ChemoTherapy 61(7):, 2017

A three-dimensional model for in vitro study of the association of three antibiotics. Application to the activity of piperacillin, tazobactam and amikacin against five strains of enterobacteria as a function of their phenotype of beta-lactam resistance. Pathologie-Biologie 46(1): 67-72, 1998

In vitro antibacterial activity of piperacillin-tazobactam in combination with netilmicin or amikacin against Enterobacteriaceae resistant to amoxicillin. Pathologie-Biologie 43(3): 208-214, 1995

In vitro combination effects of astromicin and beta-lactam antibiotics against CFS-sensitive and CFS-resistant Pseudomonas aeruginosa. In vitro synergistic activity. Japanese Journal of Antibiotics 41(5): 478-484, 1988

In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli. Antimicrobial Agents and ChemoTherapy 60(12): 7527-7529, 2016

In vitro activity of tazobactam and piperacillin combination against 224 strains of Pseudomonas aeruginosa according to the production of beta-lactamase. Pathologie-Biologie 39(5): 361-366, 1991

In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains. ChemoTherapy 49(6): 294-297, 2003

In vitro Activity of Combination Therapy with Cefepime, Piperacillin-Tazobactam, or Meropenem with Ciprofloxacin against Multidrug-Resistant Pseudomonas aeruginosa Strains. Chemotherapy 49(6): 294-297, 2003

Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria. In Vitro Susceptibility Surveillance Group. Diagnostic Microbiology and Infectious Disease 19(2): 111-120, 1994

In vitro anti microbial activity of piperacillin and 7 other beta lactam antibiotics against neisseria gonorrhoeae and haemophilus influenzae including beta lactamase producing strains. Journal of Antimicrobial Chemotherapy 5(2): 137-142, 1979

In vitro activity of fcf 22101 and other beta lactam antibiotics against enterobacteriaceae resistant to third generation cephalosporins. Journal of Antimicrobial Chemotherapy 24(2): 165-172, 1989

In vitro synthesis of peptido glycan by beta lactam sensitive and beta lactam resistant strains of neisseria gonorrhoeae effects of beta lactam and other antibiotics. Antimicrobial Agents & Chemotherapy 16(1): 28-36, 1979